{"entity":{"id":"nct02000089","kind":"trial","name":"The Cancer of the Pancreas Screening-5 CAPS5)Study","aka":["CAPS5"],"tldr":"A phase 3 trial in pancreatic cancer, run by Johns Hopkins University, now recruiting.","summary":"The Cancer of the Pancreas Screening-5 CAPS5)Study is a phase 3, interventional study registered as NCT02000089 by Johns Hopkins University, with a registry enrolment figure of 9000 participants, started 2014-01-06 and due to reach its primary completion in 2028-12. Interventions recorded: Secretin; MRI; Tumor marker gene test with CA19-9. Conditions listed: Pancreas Cancer; Peutz-Jeghers Syndrome (PJS); Gene Mutation; Germline Mutation Carrier; Lynch Syndrome. Primary outcome: Evaluate pancreatic juice for early cancer markers.. Pancreatic eligibility wording from the registry: \"* Hereditary Pancreatitis or\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT02000089","url":"https://clinicaltrials.gov/study/NCT02000089"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["pancreatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02000089","phase":"3","setting":"The Cancer of the Pancreas Screening-5 CAPS5)Study","sponsor":"Johns Hopkins University","enrolled":9000,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02000089/","neighbours":{"cancer":[{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}